Gabriel Ocana Santero net worth
Quick answer
Gabriel Ocana Santero's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Gabriel Ocana Santero is Founder at Exin Therapeutics. Exin Therapeutics valuation.
Gabriel Ocana Santero is Founder at Exin Therapeutics (YC W25). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 9
- Website: https://www.exintherapeutics.com/
Who is Gabriel Ocana Santero?
Gabriel Ocana Santero is a founder at Exin Therapeutics, which was part of Y Combinator's W25 cohort.
About Exin Therapeutics
We use AI and high-throughput mouse studies to discover therapeutics that modify neural activity in the brain. The initial focus is on epilepsies associated with autism and Parkinson’s disease with the potential to expand to any neurological disorder underlined by a dysfunction in neural activity. Our R&D is guided by AI models trained on high-density multimodal mouse data generated in-house.
We are 3...
FAQ: Gabriel Ocana Santero net worth and Exin Therapeutics valuation
What is Gabriel Ocana Santero's net worth?
Gabriel Ocana Santero's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Gabriel Ocana Santero is Founder at Exin Therapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Exin Therapeutics valuation?
Exin Therapeutics's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Gabriel Ocana Santero's role?
Gabriel Ocana Santero is Founder at Exin Therapeutics, a Y Combinator-backed startup (batch W25).